1. Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
- Author
-
Masashi Miyaoka, Genki Takahashi, Tsuyoshi Oguma, Koichiro Asano, Shigeaki Hattori, Kyoko Niimi, Kana Ohshinden, Takahisa Takihara, Jun Tanaka, Hiroto Takiguchi, Keito Enokida, Yoko Ito, Naoki Hayama, Fuminari Takahashi, Mari Takahashi, Kenichi Hirabayashi, and Yukihiro Horio
- Subjects
Male ,medicine.medical_specialty ,Lung Neoplasms ,Pyridones ,Case Report ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,Idiopathic pulmonary fibrosis ,0302 clinical medicine ,immunosuppressants ,Cyclosporin a ,Internal medicine ,Internal Medicine ,Medicine ,Humans ,Lung cancer ,Lung ,Aged ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Nodule (medicine) ,General Medicine ,Pirfenidone ,medicine.disease ,idiopathic pulmonary fibrosis ,Discontinuation ,lung cancer ,medicine.anatomical_structure ,Treatment Outcome ,Prednisolone ,Carcinoma, Squamous Cell ,Cyclosporine ,030211 gastroenterology & hepatology ,pirfenidone ,medicine.symptom ,business ,cyclosporine A ,medicine.drug - Abstract
A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitial pneumonia and chronic respiratory failure. Cyclosporine A was tapered to avoid suppression of anti-tumor immunity, and pirfenidone was initiated. Within 2 months, the tumor had shrunk to 10 mm in diameter and remained regressed for 9 months. This is the first report of a non-hematologic solid organ tumor responding to the discontinuation of immunosuppressants.
- Published
- 2020